WELLS FARGO & COMPANY/MN - MONOPAR THERAPEUTICS INC ownership

MONOPAR THERAPEUTICS INC's ticker is MNPR and the CUSIP is 61023L108. A total of 14 filers reported holding MONOPAR THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of MONOPAR THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$20
-28.6%
330.0%0.00%
Q2 2023$28
-34.9%
33
+6.5%
0.00%
Q1 2023$43
-41.1%
310.0%0.00%
Q4 2022$7331
+3.3%
0.00%
Q3 2022$030
+3.4%
0.00%
Q2 2022$029
+11.5%
0.00%
Q1 2022$0260.0%0.00%
Q4 2021$0260.0%0.00%
Q3 2021$026
-3.7%
0.00%
Q2 2021$027
+42.1%
0.00%
Q1 2021$0190.0%0.00%
Q4 2020$019
+35.7%
0.00%
Q3 2020$0140.00%
Other shareholders
MONOPAR THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Windsor Advisory Group, LLC 89,974$55,7750.13%
Rappaport Reiches Capital Management, LLC 10,695$6,6300.00%
Tower Research Capital LLC (TRC) 3,727$2,3110.00%
JPMORGAN CHASE & CO 4$20.00%
VANGUARD GROUP INC 87,596$54,3010.00%
UBS Group AG 72$450.00%
WELLS FARGO & COMPANY/MN 33$200.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 41,199$23,4830.00%
MILLENNIUM MANAGEMENT LLC 19,008$10,8350.00%
View complete list of MONOPAR THERAPEUTICS INC shareholders